Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 4461-4470 of 10862

Edit search filters
  1. A Study to Evaluate Regorafenib with Cetuximab or Panitumumab to Treat Unresectable, Locally Advanced, or Metastatic Colorectal Cancer

    Rochester, MN, Scottsdale/Phoenix, AZ

  2. A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases

    Scottsdale/Phoenix, AZ

  3. A Study of a Multi-Modal Sensor Patch for Real-Time Physiological Monitoring and Inference

    Scottsdale/Phoenix, AZ

  4. The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies

    Scottsdale/Phoenix, AZ

  5. Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)

  6. Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)

    Rochester, MN

  7. Project 2: Strategies for Reducing Nicotine Content in Cigarettes

    Scottsdale/Phoenix, AZ

  8. (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive

    Rochester, MN

  9. Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures after Endotherapy

    Jacksonville, FL

  10. Epigenetics and the Origin of Muscle Insulin Resistance in Humans

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer